BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 23523695)

  • 1. Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia.
    Takahashi S; Ukai S; Kose A; Hashimoto T; Iwatani J; Okumura M; Tsuji T; Shinosaki K
    Schizophr Res; 2013 May; 146(1-3):238-43. PubMed ID: 23523695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairments in motor-cortical inhibitory networks across recent-onset and chronic schizophrenia: a cross-sectional TMS Study.
    Strube W; Wobrock T; Bunse T; Palm U; Padberg F; Malchow B; Falkai P; Hasan A
    Behav Brain Res; 2014 May; 264():17-25. PubMed ID: 24509248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cortical inhibition in first-episode schizophrenia.
    Wobrock T; Schneider M; Kadovic D; Schneider-Axmann T; Ecker UK; Retz W; Rösler M; Falkai P
    Schizophr Res; 2008 Oct; 105(1-3):252-61. PubMed ID: 18625547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficits in GABAA receptor function and working memory in non-smokers with schizophrenia.
    Bridgman AC; Barr MS; Goodman MS; Chen R; Rajji TK; Daskalakis ZJ; George TP
    Schizophr Res; 2016 Mar; 171(1-3):125-30. PubMed ID: 26796540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation.
    Wobrock T; Schneider-Axmann T; Retz W; Rösler M; Kadovic D; Falkai P; Schneider M
    Pharmacopsychiatry; 2009 Sep; 42(5):194-201. PubMed ID: 19724982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cortical inhibition in persons with schizophrenia treated with clozapine.
    Daskalakis ZJ; Christensen BK; Fitzgerald PB; Moller B; Fountain SI; Chen R
    J Psychopharmacol; 2008 Mar; 22(2):203-9. PubMed ID: 18308816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in thresholds for intracortical excitability in chronic stroke: more than just altered intracortical inhibition.
    Edwards JD; Meehan SK; Linsdell MA; Borich MR; Anbarani K; Jones PW; Ferris J; Boyd LA
    Restor Neurol Neurosci; 2013; 31(6):693-705. PubMed ID: 23963339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered cortical processing of motor inhibition in schizophrenia.
    Lindberg PG; Térémetz M; Charron S; Kebir O; Saby A; Bendjemaa N; Lion S; Crépon B; Gaillard R; Oppenheim C; Krebs MO; Amado I
    Cortex; 2016 Dec; 85():1-12. PubMed ID: 27770667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse.
    Wobrock T; Hasan A; Malchow B; Wolff-Menzler C; Guse B; Lang N; Schneider-Axmann T; Ecker UK; Falkai P
    Psychopharmacology (Berl); 2010 Feb; 208(3):353-63. PubMed ID: 19997844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-retest reliability of short-interval intracortical inhibition and intracortical facilitation in patients with schizophrenia.
    Du X; Hong LE
    Psychiatry Res; 2018 Sep; 267():575-581. PubMed ID: 30032068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A similar but distinctive pattern of impaired cortical excitability in first-episode schizophrenia and ADHD.
    Hasan A; Schneider M; Schneider-Axmann T; Ruge D; Retz W; Rösler M; Falkai P; Wobrock T
    Neuropsychobiology; 2013; 67(2):74-83. PubMed ID: 23295893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of position and stimulation parameters on intracortical inhibition and facilitation in human tongue motor cortex.
    Kothari M; Svensson P; Nielsen JF; Baad-Hansen L
    Brain Res; 2014 Apr; 1557():83-9. PubMed ID: 24534367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic treatment with quetiapine increases the cortical silent period.
    Frank E; Landgrebe M; Poeppl TB; Schecklmann M; Kreuzer PM; Prasser J; Rupprecht R; Eichhammer P; Hajak G; Langguth B
    Schizophr Res; 2014 Jun; 156(1):128-32. PubMed ID: 24794881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study.
    Hasan A; Wobrock T; Grefkes C; Labusga M; Levold K; Schneider-Axmann T; Falkai P; Müller H; Klosterkötter J; Bechdolf A
    Biol Psychiatry; 2012 Nov; 72(9):744-51. PubMed ID: 22502988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of long-term high frequency repetitive transcranial magnetic stimulation on working memory in schizophrenia and healthy controls--a randomized placebo-controlled, double-blind fMRI study.
    Guse B; Falkai P; Gruber O; Whalley H; Gibson L; Hasan A; Obst K; Dechent P; McIntosh A; Suchan B; Wobrock T
    Behav Brain Res; 2013 Jan; 237():300-7. PubMed ID: 23022750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged cortical silent period among drug-naive subjects at ultra-high risk of psychosis.
    Tang Y; Zhang T; Edelman B; Zeng B; Zhao S; Li C; Zhuo K; Qian Z; Li H; Guo Q; Cui H; Zhu Y; Jiang L; Li C; Yu D; Wang J
    Schizophr Res; 2014 Dec; 160(1-3):124-30. PubMed ID: 25458861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient GABABergic and glutamatergic excitability in the motor cortex of patients with long-COVID and cognitive impairment.
    Manganotti P; Michelutti M; Furlanis G; Deodato M; Buoite Stella A
    Clin Neurophysiol; 2023 Jul; 151():83-91. PubMed ID: 37210757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of short-interval intracortical inhibition (SICI) and short-interval intracortical facilitation (SICF).
    Peurala SH; Müller-Dahlhaus JF; Arai N; Ziemann U
    Clin Neurophysiol; 2008 Oct; 119(10):2291-7. PubMed ID: 18723394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in response control within at-risk gamblers and non-gambling controls explained by GABAergic inhibition in the motor cortex.
    Chowdhury NS; Livesey EJ; Blaszczynski A; Harris JA
    Cortex; 2018 Jun; 103():153-163. PubMed ID: 29635162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.